John Maiorino
Medical · Lindenhurst, NYNPI 1871635698
Payments from drug & device makers
Across 225 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Lilly USA, LLC$580
- AbbVie$464
- GSK$397
- Merck$257
- Novo Nordisk$235
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,439100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 62 | $1,333 |
| Lilly USA, LLC | 31 | $580 |
| AbbVie | 23 | $464 |
| GSK | 20 | $397 |
| Merck | 16 | $257 |
| Novo Nordisk | 15 | $235 |
| Otsuka America Pharmaceutical, Inc. | 6 | $180 |
| Pfizer | 9 | $153 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Boehringer Ingelheim | 7 | $118 |
| Bayer | 4 | $80 |
| Sanofi Pasteur Inc. | 4 | $78 |
| Kowa Pharmaceuticals America, Inc. | 5 | $70 |
| Lundbeck LLC | 4 | $65 |
| Amgen | 3 | $64 |
| Amarin Pharma, Inc. | 4 | $62 |
| Exact Sciences | 3 | $56 |
| Astellas Pharma US Inc | 2 | $41 |
| Althera Pharmaceuticals LLC | 1 | $19 |
| Novartis | 1 | $16 |
| Phadia US Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| Bausch Health US, LLC | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,446 in reported general payments places this provider in the 85th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 32 | $39,708 |
| FarxigaDapagliflozin Propanediol | 25 | $31,785 |
| EliquisApixaban | 23 | $24,244 |
| OzempicSemaglutide | 11 | $12,268 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $5,795 |
| Atorvastatin Calcium | 312 | $2,320 |
| Metoprolol Succinate | 119 | $1,860 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $1,105 |
| Levothyroxine Sodium | 119 | $1,097 |
| SynthroidLevothyroxine Sodium | 15 | $828 |
| Metformin Hcl | 141 | $734 |
| Bupropion XlBupropion Hcl | 20 | $693 |
| Fluticasone Propionate | 74 | $636 |
| Amlodipine Besylate | 153 | $634 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 18 | $593 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $118 | $39,70832 claims |
| AstraZenecaFarxiga | $1,333 | $31,78525 claims |
| PfizerEliquis | $153 | $24,24423 claims |
| Novo NordiskOzempic | $235 | $12,26811 claims |
| GSKBreo Ellipta | $397 | $5,79511 claims |
| AbbVieSynthroid | $464 | $82815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,395 medical providers in New York.
Other medical in Lindenhurst
- Thomas CipollaLindenhurst$23K
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.